Table A2.
Author/Year | Country | Type of Stroke | Intervention | N | Mean Age (Years) | Time | p-Value | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Gender (Male) | Intervention | Control | Intervention | Control | Post-Incident Stroke | Endpoint | Baseline vs. Post | Baseline vs. Follow-Up | ||||
Ingrid G L van de Port, 2012 | Netherlands | Ischemic and Haemorrhagic |
CT | 162 | CT = 125 | AU = 117 | 56 | 58 | N/A | 24 weeks | >0.05 | >0.05 |
Sylvia Nguyen, 2017 | Australia | Ischemic and Haemorrhagic |
CBT | 11 | CBT = 9 | AU = 6 | 47 | 51 | 27 months | 16 weeks | <0.05 | <0.05 |
Lv Huila, 2017 | China | Ischemic and Haemorrhagic |
MT | 24 | MT = 20 | AU = 20 | 62 | 62 | 2.28 months | 8 weeks | <0.05 | N/A |
Yin Hongna, 2016 | China | Ischemic and Haemorrhagic |
TCM | 33 | AT = 30 | AU = 30 | 62 | 62 | 2.95 months | 4 weeks | <0.05 | N/A |
Wang Rongyun, 2017 | China | Ischemic and Haemorrhagic |
TCM | 45 | AT = 38 | AU = 39 | 67 | 67 | 2 weeks | 2 weeks | <0.05 | N/A |
Li Lanhua, 2014 | China | Ischemic and Haemorrhagic |
TCM | 51 | AT = 46 | AU = 45 | 51 | 51 | 27days- 20 months |
4 weeks | <0.05 | N/A |
Liu Vanjin, 2018 | China | Ischemic and Haemorrhagic |
CBT | N/A | CBT = 30 | AU = 30 | N/A | N/A | N/A | 8 weeks | <0.05 | N/A |
Li Qianfeng, 2017 | China | Ischemic | MT RT MT+RT |
47 | MT = 20 RT = 20 MT + RT = 20 |
AU = 20 | 57 | 57 | N/A | 8 weeks | <0.05 | N/A |
Liu Fengli, 2017 | China | Ischemic and Haemorrhagic |
CHM | 43 | CHM = 45 | AU = 45 | 47 | 49 | N/A | 12 weeks | <0.05 | N/A |
Zhang Libo, 2014 | China | Ischemic and Haemorrhagic |
HOT | N/A | HOT = 31 | AU = 31 | N/A | N/A | N/A | 4 weeks | <0.05 | N/A |
FSS: Fatigue Severity Scale; CT: circuit training; AU: treatment, nursing, rehabilitation as usual; CBT: cognitive behavioral therapy; MT: music therapy; TCM: Traditional Chinese Medicine; RT: respiratory training; CHM: community health management; HOT: hyperbaric oxygen therapy; N/A: not available; there are two p values in the table, the first is FSS scores of baseline vs post and the second is FSS scores of baseline vs follow-up, and only two studies had follow-up data.